B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

LIN28A

MOLECULAR TARGET

lin-28 RNA binding posttranscriptional regulator A

UniProt: Q9H9Z2NCBI Gene: 797271 compounds

LIN28A (lin-28 RNA binding posttranscriptional regulator A) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting LIN28A

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tpen0.691

About LIN28A as a Drug Target

LIN28A (lin-28 RNA binding posttranscriptional regulator A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented LIN28A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

LIN28A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.